003090.KS KSC
Daewoong Co., Ltd.
1W: -3.5%
1M: -13.8%
3M: -11.7%
YTD: -41.6%
1Y: -30.9%
3Y: +24.0%
5Y: -66.4%
₩15,340.00 ($11.39)
-250.00 (-1.60%)
Weekly Expected Move ±3.7%
₩14212
₩14776
₩15340
₩15904
₩16468
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩644.8B ($479.0M)
52W Range15040-30600
Volume55,924
Avg Volume68,215
Beta0.34
Dividend₩200.00
Analyst Ratings
No analyst coverage
Company Info
CEOYeong-Hwan Yoon
Employees413
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1973-06-26
Websitedaewoongholdings.com
244 Galmachi-ro
Hwaseong-si, GY
KR
Hwaseong-si, GY
KR
82 2 2190 6969
About Daewoong Co., Ltd.
Operating alongside its various subsidiaries, Daewoong Co., Ltd. is primarily engaged in the production and sale of pharmaceutical products. Additionally, the company generates income from real estate leasing. Established in 1961, the firm transitioned its name from Daewoong Pharmaceutical Co., Ltd. to its current designation, Daewoong Co., Ltd., in 2002. Its corporate headquarters are located in Seongnam-si, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found